It enhances the sensitivity of cancer cells to chemotherapy drugs by affecting the expression of pathways such as MAPK, PI3K/AKT, and NF-κB in cancer cells, thus inducing apoptosis in acute myeloid leukemia, prostate cancer, breast cancer, lung cancer, gastric cancer, and liver cancer [12]. Here, NFKB1 is linked to cancer.